Andrew Komjathy - Net Worth and Insider Trading
Andrew Komjathy Net Worth
The estimated net worth of Andrew Komjathy is at least $900 dollars as of 2024-04-28. Andrew Komjathy is the Chief Commercial Officer of Astria Therapeutics Inc and owns about 100 shares of Astria Therapeutics Inc (ATXS) stock worth over $900. Details can be seen in Andrew Komjathy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Komjathy has not made any transactions after 2021-11-19 and currently still holds the listed stock(s).
Transaction Summary of Andrew Komjathy
Andrew Komjathy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Komjathy owns 1 companies in total, including Astria Therapeutics Inc (ATXS) .
Click here to see the complete history of Andrew Komjathy’s form 4 insider trades.
Insider Ownership Summary of Andrew Komjathy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2021-11-19 | Chief Commercial Officer |
Andrew Komjathy Latest Holdings Summary
Andrew Komjathy currently owns a total of 1 stock. Andrew Komjathy owns 100 shares of Astria Therapeutics Inc (ATXS) as of November 19, 2021, with a value of $900.
Latest Holdings of Andrew Komjathy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2021-11-19 | 100 | 9.00 | 900 |
Holding Weightings of Andrew Komjathy
Andrew Komjathy Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Komjathy has made a total of 1 transactions in Astria Therapeutics Inc (ATXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Astria Therapeutics Inc is the acquisition of 100 shares on November 19, 2021, which cost Andrew Komjathy around $670.
Insider Trading History of Andrew Komjathy
- 1
Andrew Komjathy Trading Performance
GuruFocus tracks the stock performance after each of Andrew Komjathy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Komjathy is -5.3%. GuruFocus also compares Andrew Komjathy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Komjathy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Komjathy's insider trading performs compared to the benchmark.
Performance of Andrew Komjathy
Average Return
32.73%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.12 | -5.3 | -42.42 | 32.73 | -18.21 | |
| Relative Return to S&P 500(%) | -15.47 | 2.13 | -25.45 | 48.32 | -16.23 |
Andrew Komjathy Ownership Network
Ownership Network List of Andrew Komjathy
Ownership Network Relation of Andrew Komjathy
Andrew Komjathy Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Andrew Komjathy is the Chief Commercial Officer of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Andrew Komjathy made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 20,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 2,481,350 shares, with a net purchase of 2,461,350 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Andrew Komjathy Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Komjathy. You might contact Andrew Komjathy via mailing address: Catabasis Pharmaceuticals, Inc., One Kendall Square, Suite B14202, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
